FairValueLabs Valuation System Value Investment
CPRT

Copart, Inc. (CPRT) Stock Analysis — Fair Value, Risk & Moat Rating

NMS · Industrials · Specialty Business Services

$33.68 Overvalued -0.06 (-0.2%) As of Apr 22, 2026 Not a buy/sell recommendation. See disclaimer.
Overall Verdict Caution
24.88
Altman Z-ScoreSafe Zone
$28.08
Fair ValueOvervalued (-19.9%)
3.4
Moat RatingNarrow moat
TL;DR · Audit Summary

Is Copart, Inc. a safe investment right now?

Copart, Inc.'s Altman Z-Score of 24.88 places it in the safe zone. Our fair value estimate is $28.08 (Overvalued). Moat rating: 3.4/5 stars.

Price Chart · CPRT
Section 01 · Financial Health

Could Copart, Inc. go bankrupt? Altman Z-Score analysis

24.88

Z-Score of 24.88 is above 3.0, indicating the company is financially healthy by this metric.

  • Below 1.8 — Distress Zone (high bankruptcy risk)
  • 1.8 to 3.0 — Gray Zone (elevated uncertainty)
  • Above 3.0 — Safe Zone (financially healthy)

What drives CPRT's Z-Score?

Altman Z-Score components for CPRT
ComponentFormulaValueWeightContribution
A · Working Capital / Total AssetsWC / TA0.50261.20.6
B · Retained Earnings / Total AssetsRE / TA0.8021.41.12
C · EBIT / Total AssetsEBIT / TA0.16813.30.55
D · Market Cap / Total LiabilitiesMCap / TL36.90560.622.14
E · Revenue / Total AssetsRev / TA0.46051.00.46

How has CPRT's financial health changed over time?

3.0 Safe1.8 Distress0.09.118.227.236.32022202320242025
CPRT Z-Score history
YearZ-ScoreZone
202231.59Safe
202328.94Safe
202424.99Safe
202524.88Safe

Source: Calculated from CPRT's latest 10-K filing on SEC EDGAR.

Section 02 · Fair Value Estimate

What is Copart, Inc. actually worth?

FVL Fair Value$28.08
vs
Market Price$33.68
Overvalued -19.9% Stock trades 19.9% above our estimated fair value of $28.08.

How we calculated this

FVL Valuation Model
InputValueSource
Predicted EPS (α)$1.56Proprietary blend of reported actuals (2Q actual) + analyst consensus, weighted by α
Last Year EPS$1.59Annual report (SEC EDGAR)
Analyst Consensus EPS (This Year)$1.579 analysts consensus
Trailing P/E21.2xCurrent market pricing
Fair P/E (β discount)18.0xTrailing PE adjusted by value discount factor β, hard-capped
Earnings Trend (γ)StableDirectional signal: predicted vs trailing EPS

Wall Street Reference: Analyst consensus target price is $42.67 (9 analysts). This is shown for reference only and is not used in our valuation model.

Source: Earnings data from SEC EDGAR filings. Market data via Yahoo Finance.

Section 03 · Competitive Moat

Does Copart, Inc. have a durable competitive advantage?

★★★☆☆
Narrow moat

Moat rating: 3.4/5.

What makes up CPRT's moat score?

ROIC Stability

★★★★☆

ROIC variability over the past decade. Score: 4/5.

Gross Margin Trend

★★★☆☆

Gross margin trajectory over the past decade. Score: 3/5.

Switching Costs

★★★☆☆

Estimated customer lock-in based on margin level. Score: 3/5.

How stable is CPRT's return on invested capital?

0%-5%5%15%25%35%2022202320242025
CPRT ROIC history
YearROICTrend
202229.7%
202324.8%Declining
202420.9%Declining
202518.5%Declining

Source: ROIC calculated from SEC EDGAR filings.

Section 04 · Dividend Safety

Is Copart, Inc.'s dividend safe?

Status Suspended Copart, Inc. has suspended its dividend. No payout is currently being made to shareholders.
Section 05 · Financial Summary

Copart, Inc.'s key financial metrics

CPRT financial summary
MetricLatest1Y Ago3Y AgoTrend
Revenue $4.6B $4.2B $3.5B Rising
Net Income $1.6B $1.4B $1.1B Rising
Free Cash Flow $1.2B $1.0B $0.8B Rising
Gross Margin 45.2% 45.0% 45.9% Stable
Section 06 · Lab Signals

Recent events that affect our CPRT analysis

EARNINGS

CPRT earnings report scheduled

Lab Impact

Upcoming report. Consensus EPS estimate: $0.41. Revenue estimate: $1.20B. Our current Fair Value: $28.08 — a significant beat or miss could shift this estimate.

ANALYST

CPRT analyst consensus: 50% bullish (6 of 12 analysts)

Lab Impact

3 Strong Buy, 3 Buy, 5 Hold, 0 Sell, 1 Strong Sell. Consensus target: $42.67 (26.7% upside). Compare with our independent Fair Value: $28.08.

FILING

CPRT filed quarterly report (10-Q)

Lab Impact

Quarterly update with interim financials. May signal changes to earnings trajectory and balance sheet health. View on SEC EDGAR →

EARNINGS

CPRT missed EPS estimates by 7.5%

Lab Impact

Reported EPS: $0.36 vs estimate $0.39. Our Fair Value of $28.08 may face downward pressure if the trend continues.

FILING

CPRT filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

FILING

CPRT filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

FILING

CPRT filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

FILING

CPRT filed quarterly report (10-Q)

Lab Impact

Quarterly update with interim financials. May signal changes to earnings trajectory and balance sheet health. View on SEC EDGAR →

EARNINGS

CPRT beat EPS estimates by 5.1%

Lab Impact

Reported EPS: $0.41 vs estimate $0.39. Earnings strength supports our Fair Value of $28.08 (16.6% below current price).

FILING

CPRT filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

FILING

CPRT filed annual report (10-K)

Lab Impact

Annual filing with full-year financials. Our Altman Z-Score, Moat, and Fair Value models are derived from this data. View on SEC EDGAR →

EARNINGS

CPRT beat EPS estimates by 13.3%

Lab Impact

Reported EPS: $0.41 vs estimate $0.36. Earnings strength supports our Fair Value of $28.08 (16.6% below current price).

FILING

CPRT filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

FILING

CPRT filed quarterly report (10-Q)

Lab Impact

Quarterly update with interim financials. May signal changes to earnings trajectory and balance sheet health. View on SEC EDGAR →

EARNINGS

CPRT beat EPS estimates by 0.8%

Lab Impact

Reported EPS: $0.42 vs estimate $0.42. Earnings strength supports our Fair Value of $28.08 (16.6% below current price).

FILING

CPRT filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

FILING

CPRT filed quarterly report (10-Q)

Lab Impact

Quarterly update with interim financials. May signal changes to earnings trajectory and balance sheet health. View on SEC EDGAR →

EARNINGS

CPRT beat EPS estimates by 7.5%

Lab Impact

Reported EPS: $0.40 vs estimate $0.37. Earnings strength supports our Fair Value of $28.08 (16.6% below current price).

FILING

CPRT filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

Section 07 · FAQ

Common questions about Copart, Inc.

What is Copart, Inc. stock price today?

Copart, Inc. (CPRT) stock price is $33.68 as of the latest market close, traded on the NASDAQ exchange.

What does Copart, Inc. do?

Copart, Inc. provides online auctions and vehicle remarketing services in the United States, the United Kingdom, Germany, Brazil, Canada, the United Arab Emirates, Spain, Finland, Oman, the Republic of Ireland, and Bahrain. It offers a range of services to process and sell vehicles over the internet through its virtual bidding third generation internet auction-style sales technology.

What is Copart, Inc. market cap?

Copart, Inc. has a market capitalization of $32.60B, classifying it as a large-cap stock in the Industrials sector.

What sector and industry is CPRT in?

Copart, Inc. operates in the Industrials sector, specifically within the Specialty Business Services industry. It trades on the NASDAQ under the ticker symbol CPRT.

Is CPRT stock overvalued or undervalued?

Based on our valuation model, Copart, Inc. trades 19.9% above our fair value estimate — potentially overvalued.

  • FairValueLabs Fair Value: $28.08
  • Current Price: $33.68
  • Valuation Zone: Overvalued
What is CPRT stock forecast and analyst target price?

Based on 9 Wall Street analysts, the consensus price target for Copart, Inc. is $42.67, implying upside of 26.7% from the current price.

  • Analyst High Target: $55.00
  • Analyst Low Target: $32.00

Note: Analyst targets are shown for reference and are not used in our valuation model.

Is Copart, Inc. revenue and earnings growing?

Here are the analyst consensus growth estimates for Copart, Inc.:

  • Revenue growth (current year est.): -0.9%
  • EPS growth (current year est.): -1.0%
  • Revenue growth (next year est.): 4.7%
  • EPS growth (next year est.): 6.7%
What are Copart, Inc.'s key financial metrics?
MetricLatestTrend
Revenue$4.6BRising
Net Income$1.6BRising
Free Cash Flow$1.2BRising
Gross Margin45.2%Stable
What is CPRT's P/E ratio?

The price-to-earnings ratio measures how much investors pay per dollar of earnings:

  • Trailing P/E (last 12 months): 21.2x
  • Forward P/E (next 12 months est.): 20.1x
  • FairValueLabs Fair P/E: 18.0x
How volatile is CPRT stock?

Copart, Inc. has a beta of 1.14, meaning it is somewhat more volatile than the broader market. A beta above 1.0 indicates higher price swings relative to the S&P 500, while below 1.0 suggests more stability.

How much cash and debt does Copart, Inc. have?

Copart, Inc.'s balance sheet shows:

  • Total Cash: $5.10B
  • Total Debt: $96.1M
  • Net Cash Position: $5.01B

A positive net cash position means the company holds more cash than debt, reducing financial risk.

What is Copart, Inc.'s free cash flow?

Copart, Inc. generated $1.04B in trailing twelve-month free cash flow (from $1.80B in operating cash flow). Free cash flow represents the cash available for dividends, buybacks, and debt reduction after all capital expenditures.

Does Copart, Inc. pay a dividend?

Copart, Inc. does not currently pay a regular dividend to shareholders. The company may be reinvesting all profits back into growth, or it may have suspended its dividend.

Is Copart, Inc. at risk of going bankrupt?

Copart, Inc.'s Altman Z-Score is 24.88, placing it in the safe zone (above 3.0) — bankruptcy risk is low. The Z-Score uses five balance sheet ratios to predict bankruptcy probability within two years.

Does Copart, Inc. have a durable competitive advantage?

Copart, Inc. scores 3.4/5 stars (Narrow moat) in our moat analysis:

  • ROIC Stability: 4/5
  • Gross Margin Trend: 3/5
  • Switching Costs: 3/5

A score above 3.5 suggests meaningful pricing power and a defensible market position.

What is CPRT's return on equity (ROE)?

Copart, Inc.'s return on equity is 17.1%. ROE measures how efficiently a company generates profits from shareholder equity. An ROE above 15% is generally considered strong, while below 10% may signal inefficiency.

How do I buy CPRT stock?

CPRT shares can be purchased through any brokerage account that provides access to the NASDAQ. Common steps:

  1. Open an account with a broker (e.g., Fidelity, Schwab, Interactive Brokers)
  2. Search for ticker symbol CPRT
  3. Place a market or limit order for your desired number of shares

This is not investment advice. Always do your own research before buying any stock.

Is CPRT a value stock or speculative?

FairValueLabs classifies Copart, Inc. as Value Investment. It exhibits consistent profitability, reasonable valuation, and financial stability — characteristics of a traditional value investment.

Who is the CEO of Copart, Inc.?

The current CEO of Copart, Inc. is Mr. Jeffrey Liaw.

What is CPRT's earnings per share (EPS)?

Earnings per share measures the company's profit allocated to each outstanding share:

  • Trailing EPS (last 12 months): $1.59
  • Forward EPS (next 12 months est.): $1.68
  • Analyst consensus EPS (this year): $1.57
  • Analyst consensus EPS (next year): $1.68

FairValueLabs Disclaimer

All valuations, scores, ratings, and classifications on this page are produced by the FairValueLabs internal valuation system. They do not represent actual market value, guaranteed outcomes, or professional investment advice. These are analytical estimates for educational and research purposes only.

This is not financial advice. All data is sourced from SEC EDGAR public filings. Always consult a qualified financial advisor before making investment decisions.

Last updated: Apr 22, 2026. Data sources: SEC EDGAR (financial statements), Yahoo Finance (market data, analyst consensus). Data may not reflect the most recent quarter.

CPRT analysis methodology: How we calculate fair value, Z-Scores, and moat ratings